Company Number: 13116931

Analysis Date: 2025-07-29 20:52 UTC

Financial Health Assessment Report for IFIBRE LIMITED

---

1. Financial Health Score: Grade D

Explanation:
IFIBRE LIMITED is classified as a dormant company with minimal financial activity since incorporation in 2021. The company maintains a nominal cash balance of £10 and net assets of £10 consistently over four years. The lack of operational transactions or revenues indicates no active business operations, resulting in a financial health score of D. The company is essentially in a "financial coma" state—alive legally but showing no signs of active business vitality.

---

2. Key Vital Signs

Metric	Value (2024)	Interpretation
Cash	£10	Minimal cash on hand; no working capital to support operations.
Net Assets	£10	Very low net asset base; reflects only share capital.
Shareholders’ Funds	£10	No retained earnings or reserves, consistent with dormancy.
Account Status	Dormant	No commercial activity reported; exempt from audit.
Filing Compliance	Up to date	Accounts and returns are filed on time; no overdue filings.
Directors	Single director	Director is active with no disqualifications recorded.

Interpretation:
The company’s financials show no operational activity, with static figures at the minimal statutory level. The "vital signs" here indicate a company in stasis, with no inflow or outflow of funds, no assets beyond nominal share capital, and no liabilities. This is typical for a dormant company which may be held for future use, protection of a trading name, or as a shell entity.

---

3. Diagnosis

IFIBRE LIMITED currently exhibits the financial condition of a dormant entity. The "symptoms" include:

• No commercial transactions or revenue generation during the reported periods.
• Constant minimal cash and net asset values.
• No accrual of liabilities or assets beyond the initial share capital.
• Compliance with statutory filing requirements, indicating good administrative health.
• No financial distress signs such as debts, losses, or negative equity.

The company’s financial health is stable but inactive. It is neither generating profits nor incurring losses, placing it in a neutral but inactive zone. This condition is akin to a patient in remission or under observation without active symptoms.

---

4. Recommendations

To improve IFIBRE LIMITED’s financial wellness and avoid future risks associated with dormancy:

• Activate Trading Operations: If the intention is to develop a business, initiate commercial activities to generate revenue and build working capital.
• Regular Financial Reviews: Even if dormant, review company status annually to assess if maintaining dormancy is strategic or if dissolution/liquidation should be considered.
• Maintain Compliance: Continue timely filing of dormant accounts and confirmation statements to avoid penalties.
• Assess Future Business Plans: Clarify strategic intentions for the company—whether it will remain dormant as a holding entity or transition to active trading.
• Consider Capital Injection: If planning to trade, ensure adequate capital investment to support startup activities and avoid cash flow distress.
• Monitor Director Responsibilities: Ensure the director is fully aware of compliance duties and the implications of dormant status.

If the company remains dormant long-term without plans for activation, consider formal dissolution to reduce administrative burdens and costs.

---